PMID: 2509271Jul 1, 1989Paper

Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience

Diabetologia
E ChantelauM Berger

Abstract

A follow-up study of 116 Type 1 (insulin-dependent) diabetic patients on long-term continuous subcutaneous insulin infusion was conducted after 4.5 +/- 0.2 years. The average HbA1c-value of these patients decreased by 1% to 6.7 +/- 0.1% during this observation period. Typical side effects of continuous subcutaneous insulin infusion such as skin inflammation at the catheter insertion site occurred with similar frequency as has been reported previously by other authors. Diabetic ketoacidosis (0.14 per patient year) and disabling hypoglycaemia (0.1 per patient year, including 0.05 hypoglycaemic coma per patient-year) occurred at substantially lower rates than in other comparable studies with Type 1 diabetic patients at a similar degree of metabolic control. Subgroup evaluation suggested that a normal (less than 5.6%) HbA1c-value at follow-up was associated with increased incidence of disabling hypoglycaemia, whereas poor metabolic control (HbA1c greater than 7.5%) was associated with increased rates of skin complications and hospital treatment for ketoacidosis. Thus, under the policies of this diabetes centre, continuous subcutaneous insulin infusion has proved to be beneficial to a large proportion of experienced adult Type 1 dia...Continue Reading

References

Jan 28, 1978·British Medical Journal·J C PickupK G Alberti
Nov 29, 1986·Lancet
Feb 24, 1989·JAMA : the Journal of the American Medical Association·H P ChaseD O'Brien
Mar 1, 1986·Diabetic Medicine : a Journal of the British Diabetic Association·S M Marshall, P D Home
Apr 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·S G MelbergJ Brange
Jul 1, 1987·Diabetes Research and Clinical Practice·B RønnT Deckert
Nov 18, 1988·JAMA : the Journal of the American Medical Association·R KleinD L DeMets
Nov 1, 1986·Diabetes Care·J S Skyler
Feb 7, 1986·JAMA : the Journal of the American Medical Association·S J Brink, C Stewart
Aug 22, 1985·The New England Journal of Medicine·R S MecklenburgR L Nielsen
Jul 5, 1980·Lancet·R J Jarrett, H Keen
May 1, 1984·Diabetic Medicine : a Journal of the British Diabetic Association·J C Pickup
May 1, 1984·Diabetic Medicine : a Journal of the British Diabetic Association·P D Home, S M Marshall
May 1, 1983·Diabetologia·T LauritzenC Binder
Apr 2, 1984·Klinische Wochenschrift·E A ChantelauM Berger
Aug 9, 1984·The New England Journal of Medicine·UNKNOWN Kroc Collaborative Study Group
Sep 1, 1984·Medical & Biological Engineering & Computing·J C Pickup, D Rothwell
Feb 9, 1984·The New England Journal of Medicine·S M TeutschJ M Lane
Feb 9, 1984·The New England Journal of Medicine·D M NathanJ D Goodson
Jul 1, 1982·Clinics in Endocrinology and Metabolism·J DupreN W Rodger
Oct 1, 1982·Clinical Physiology·M BergerE A Chantelau
Jan 1, 1981·The American Journal of Medicine·R Tattersall, E Gale

❮ Previous
Next ❯

Citations

Jul 1, 1995·Diabetes/metabolism Reviews·M J CastilloP J Lefèbvre
Mar 29, 2002·Diabetes/metabolism Research and Reviews·Bruce W BodePaul C Davidson
Jul 1, 1996·Diabetologia·M Berger
Feb 1, 1997·Patient Education and Counseling·E ChantelauB Hansen
Oct 6, 1997·Endocrinology and Metabolism Clinics of North America·C D Saudek
Jun 27, 2006·Diabetes & Metabolism·I GuilhemD Maugendre
May 7, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·R Rowe
Jul 31, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·D BruttomessoA Tiengo
Mar 6, 2004·Diabetes Technology & Therapeutics·Satish K GargH Peter Chase
Jun 11, 2010·Diabetes Technology & Therapeutics·Satish K Garg
Apr 1, 1993·Journal of Internal Medicine·I Mühlhauser, M Berger
May 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·U Fischer
Mar 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·M Berger, I Mühlhauser
May 26, 2001·BMJ : British Medical Journal·J Pickup, H Keen
May 1, 2007·Regenerative Medicine·K Ananda KrishnaKrs Sambasiva Rao
Feb 13, 2013·Wiener klinische Wochenschrift·Marietta StadlerMartin Bischof
Oct 1, 1989·Baillière's Clinical Gastroenterology·E G Siegel, W Creutzfeldt
Apr 16, 2008·The Journal of Pediatrics·Louise S ConwellDenis Daneman
Dec 7, 2007·Primary Care·Russell D White
Aug 16, 2003·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Ralf Schiel
Jan 28, 2009·Diabetes/metabolism Research and Reviews·Daniela BruttomessoAldo Baritussio
May 15, 1989·Diabetes Research and Clinical Practice·M Berger
Feb 1, 1994·Diabetes Research and Clinical Practice·E SchifferdeckerH Schatz
Jan 1, 1993·Diabetes Research and Clinical Practice·R WredlingU Adamson
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Justen W Rudolph, Irl B Hirsch
Jun 26, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·L M CrawfordR J Comi
May 6, 2015·Indian Journal of Endocrinology and Metabolism·Subhash Kumar Wangnoo
Oct 29, 2002·Diabetes Care·David S Schade, Virginia Valentine
Mar 29, 2003·Diabetes Care·Jill Weissberg-BenchellRoopa Seshadri
Mar 1, 2003·Diabetes Care·Eugenio Cersosimo
Aug 28, 2012·Journal of Diabetes Science and Technology·Lutz Heinemann, Lars Krinelke
Jun 13, 2018·Diabetes Technology & Therapeutics·Anna Korsgaard BergJannet Svensson
Sep 26, 2003·American Journal of Clinical Dermatology·Tristan Richardson, David Kerr
Apr 2, 2019·Journal of Diabetes Science and Technology·Ershuai Zhang, Zhiqiang Cao
Apr 4, 2019·Diabetes Technology & Therapeutics·Maria O ChristensenKirsten Nørgaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.